Can Wei

2.3k citations
64 papers · 1.9k · 1 hit paper · h-index 23

Impact in

Papers in

Can Wei

60 papers receiving 1.8k citations

Can Wei's Hit Papers

Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF‐1α/SLC7A11 pathway 2021 · 346 citations
3460+1+3Years since publication100200300

Peers

Can Wei
Comparison fields: 5 of 105
  • Pathology and Forensic Medicine 403
  • Hepatology 123
  • Geriatrics and Gerontology 43
  • Biochemistry 69
  • Pulmonary and Respiratory Medicine 327
Replace Sehwan Jang with:
Sehwan Jang Puerto Rico
Weifeng Yao China
Amir Ajoolabady China
Hongxia Wang China
Ying Tan China
Edith Hochhauser Israel
Lele Ji China
Leilei Ma China
János Pálóczi United States
Can Wei relative to Sehwan Jang Puerto Rico Sehwan Jang's profile →
Citations per field
00.5×2×3×
Sehwan Jang · 1×
Citations per year

Countries citing papers authored by Can Wei

Since Specialization
Citations

This map shows the geographic impact of Can Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Can Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Can Wei more than expected).

Fields of papers citing papers by Can Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Can Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Can Wei. The network helps show where Can Wei may publish in the future.

Co-authors

The 25 scholars most cited alongside Can Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Can Wei Line = papers co-authored together Can Wei links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF‐1α/SLC7A11 pathway
Hit paper breakdown →
2021346
2 2014206
3 2012102
4 202273
5 201864
6 202358
7 202055
8 201554
9 201754
10 201450
11 201442
12 202040
13 201637
14 201736
15 202435
16 201333
17 202129
18 202028
19 201626
20 201224

About Can Wei

Can Wei is a scholar working on Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Molecular Biology and Biochemistry, having authored 64 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cardiac Ischemia and Reperfusion (15 papers), Cardiac Fibrosis and Remodeling (7 papers), Cardiovascular Function and Risk Factors (6 papers), Polyamine Metabolism and Applications (5 papers), Renal cell carcinoma treatment (4 papers), Liver physiology and pathology (3 papers), Sulfur Compounds in Biology (3 papers) and Gut microbiota and health (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (403 citations), Hepatology (123 citations), Geriatrics and Gerontology (43 citations), Biochemistry (69 citations) and Pulmonary and Respiratory Medicine (327 citations). Can Wei has collaborated with scholars based in China, Canada and Jordan. Frequent co-authors include Ling Fang, Changqing Xu, Jiahao Li, Guofang Liu, Siyu Yuan, Lijun Zhang, Lingling Li, Shiyi Cai, Jing Li and Andrew N. Redington. Their work appears in journals such as Cell Biology International, Basic Research in Cardiology, International Journal of Molecular Medicine, Cell & Bioscience and mSystems.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact